Navigation Links
Positive Findings Published on Emergent Technology for Treating Chronic Pain
Date:8/19/2008

PHILADELPHIA, Aug. 20 /PRNewswire/ -- Peer-reviewed safety and efficacy data on Electrical Twitch Obtaining Intramuscular Stimulation (eToims(R)), successfully applied to patients suffering from treatment-resistant chronic pain appeared in the August/September issue of Electromyography and Clinical Neurophysiology. The findings reported by University of Pennsylvania associated physicians Jennifer Chu, M.D. and Ira Schwartz, M.D., Ph.D., represent an important advancement in understanding this debilitating disease.

"Seventy-six million Americans, including Olympic athletes suffer from constant long-standing muscle pain, for which treatment is elusive", says Dr. Chu, Associate Professor of Physical Medicine and Rehabilitation, and faculty at the University of Pennsylvania's Medical School for over 30 years. "This study demonstrates a ground-breaking, non-invasive and drug-free approach that controls and may ultimately eliminate the most common cause of muscle pain".

eToims(R)-related neuromuscular pain research began in 1990, combining 5,000-year-old art of acupuncture with modern technology applied to anatomical and neurophysiological science. In 2006, eToims(R) became non-invasive replacing needle use with a handheld electrical wand. eToims(R) produces muscle twitches by stimulating deep neuromuscular junctions at multiple body areas relieving muscle tightness, differentiating it from all other invasive and noninvasive neuromuscular stimulation.

The results were from 92 patients aged 20 to 82 years, with long standing, treatment non-responsive muscle pain, who paid for ongoing eToims(R) treatments. Pain relief was more definitive in those receiving 3Hz frequency electrical stimulation for 4 seconds than 1Hz for 1 second, establishing the therapeutic importance of low-frequency repetitive stimulation. There were no noted complications or adverse effects from weekly or bi-weekly treatments applied over 18 months.

Twitch-induced pain relief results from effective internal stretching of nerve-related, pain producing shortened muscles. The scientific deep massage effects relax muscles, release entrapped nerves, decrease traction on pain- sensitive structures, increase oxygen-rich blood inflow to, and pain-producing chemical outflow from affected areas.

eToims(R) Medical Technology, LLC developed and patented the eToims(R) system (http://www.stopmusclepain.com) and was recently named one of Philadelphia's Top 3 Emerging Biotechnology Companies by Benjamin Franklin Technology Partners. In September, the company will present at AdvaMed 2008: The MedTech Conference (http://www.advamed2008.com) in Washington D.C. eToims(R) Medical Technology is expected to receive relevant U.S. and European regulatory clearance before the end of 2008.

John Wannenburg

RP&W

(610)688-3164

john@robinsonpacker.com

Jennifer Chu, M.D.

eToims(R) Medical Technology

(215)387-0550

jchu@etoims.com

http://www.stopmusclepain.com


'/>"/>
SOURCE eToims Medical Technology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons TOGETHER Launches Across the Nation
2. Losing weight soon after type 2 diabetes diagnosis doubles positive outcomes
3. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Moodys Investors Service
4. Canadian study of colds and kids: Positive safety results for ginseng extract
5. New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation
6. UK Businesses Urged to Help Employees Deal With Stress More Positively
7. Positive thinking is prescription for the heart
8. Cardiome Announces Positive Phase 2b Results For Oral Vernakalant
9. Awareness of epidemiologys limitations could reduce impact of false-positive cancer results
10. Its the Same Old Song: Accentuate the Positive as New York State Department of Health Releases Statewide Hospital Infection Rates
11. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Standard & Poors Rating Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the ... in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on ... health management. , ODH will also have an exhibit booth where attendees may speak ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ability to sharpen ... With ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, horizontal ... color spectrum tools users can visually see the color range effected with ease all ...
(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... Dr. Ronald E. Hawkins, vice president for academic affairs ... Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of Liberty ... to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), where ...
(Date:2/24/2017)... ... February 24, 2017 , ... With millions of ... critically important that we all are aware of our options and are empowered ... to announce the launch of its newest edition of "Vision and Hearing" in ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: